Items Tagged ‘antiplatelet’
July 19, 2021 · Leave a Comment
Mayo Clinic Research in the news — 7/19/2021
By Advancing the Science contributor 
Mayo research and faculty expertise were cited on topics such as the health benefits of a pet, narcolepsy, the benefits of second opinions for patient outcomes, hiccups, COVID-19 modeling and a variety of other healthcare concerns. Star Tribune, Competing models at start of pandemic hurt public’s trust … Mayo leaders in spring 2020 reached out […]
View full entry Comment on this
Tags: Abinash Virk, aging, Alzheimer's disease, Andrew Badley, Andrew Jagim, anemia, animal model, antiplatelet, anxiety, artificial intelligence, bioethics, biomedical ethics
April 26, 2021 · Leave a Comment
Mayo Clinic Research in the news — 4/26/2021
Catch up on some of the news about Mayo Clinic’s research and faculty experts. Among the topics covered are artificial intelligence, women’s sexual health, genetic implications for several conditions, and COVID-19. AI caught a hidden problem in one patient’s heart. Can it work for others? STAT 4/26/2021 … Specifically, the algorithm, created by physicians at […]
View full entry Comment on this
Tags: AFib, amyloidosis, antiplatelet, artificial intelligence, atrial fibrillation, Center for the Science of Health Care Delivery, Charanjit Rihal, colorectal cancer, COVID-19, Dawn Marie Davis, dermatology, Donald Hensrud
March 22, 2021 · Leave a Comment
Mayo Clinic Research in the news — 3/22/2021
News including Mayo Clinic research and research expertise this week covered a wide range of topics, including genetic testing to inform prescribing blood thinners and therapies for bile duct and gall bladder cancers. A number of women’s health related articles highlighted Mayo Clinic research, there were some arguments for naps, and the ever present COVID-19 […]
View full entry Comment on this
Tags: antiplatelet, asthma, bile duct cancer, breast cancer, COVID-19, Diego Zaquera Carvalho, Elizabeth Stewart, gall bladder cancer, gastroenterology, genetic testing, genetics, genomics
September 3, 2020 · Leave a Comment
By Advancing the Science contributor
Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement― nonsurgical procedures to improve blood flow to the heart ― are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in cardiology, suggests that genetic testing could […]
View full entry Comment on this
Tags: angioplasty, antiplatelet, cardiology, Center for Individualized Medicine, Charanjit Rihal, clinical trials, coronary artery disease, gene variant, genetics, heart disease, Kent Bailey, Michael Farkouh
August 5, 2019 · Leave a Comment
Blood thinners in combination increase bleeding risk, Mayo study finds
Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]
View full entry Comment on this
Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao